Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified. more
| Time Frame | HELX | S&P500 |
|---|---|---|
| 1-Week Return | -4.81% | 1.92% |
| 1-Month Return | 1.87% | 1.46% |
| 3-Month Return | 3.26% | 3.97% |
| 6-Month Return | 27.31% | 17.87% |
| 1-Year Return | 30.81% | 16.12% |
| 3-Year Return | 50.43% | 79.85% |
| 5-Year Return | -16.19% | 77.15% |
| 10-Year Return | 77.04% | 261.76% |
| Time Frame | HELX | S&P500 |
|---|---|---|
| 1-Week Return | -92.35% | 169.57% |
| 1-Month Return | 25.28% | 19.29% |
| 3-Month Return | 13.89% | 17.10% |
| 6-Month Return | 63.17% | 39.57% |
| 1-Year Return | 30.81% | 16.12% |
| 3-Year Return | 14.58% | 21.61% |
| 5-Year Return | -3.47% | 12.12% |
| 10-Year Return | 5.88% | 13.72% |
| Stock name | Ticker | Weight |
|---|---|---|
NATERA INC
|
NTRA |
10.26%
|
GUARDANT HEALTH INC
|
GH |
9.8%
|
TWIST BIOSCIENCE CORP
|
TWST |
5.2%
|
KRYSTAL BIOTECH INC
|
KRYS |
4.99%
|
ADAPTIVE BIOTECHNOLOGIES
|
ADPT |
4.8%
|
LIGAND PHARMACEUTICALS
|
LGND |
4.39%
|
BRIDGEBIO PHARMA INC
|
BBIO |
2.88%
|
TRAVERE THERAPEUTICS INC
|
TVTX |
2.62%
|
MEDPACE HOLDINGS INC
|
MEDP |
2.58%
|
VERTEX PHARMACEUTICALS IN
|
VRTX |
2.54%
|
UNITED THERAPEUTICS CORP
|
UTHR |
2.52%
|
ELI LILLY & CO
|
LLY |
2.23%
|
GRAIL INC
|
GRAL |
2.08%
|
TEMPUS AI INC-CL A
|
TEM |
2.04%
|
VYLOR INC
|
VYLR |
2%
|
REPLIGEN CORP
|
RGEN |
1.97%
|
REGENERON PHARMACEUTICALS
|
REGN |
1.93%
|
CAREDX INC
|
CDNA |
1.75%
|
ARGENX SE
|
ARGX.BR |
1.48%
|
CHARLES RIVER LABORATORIE
|
CRL |
1.47%
|
10X GENOMICS INC-CLASS A
|
TXG |
1.43%
|
NEUROCRINE BIOSCIENCES IN
|
NBIX |
1.43%
|
JAZZ PHARMACEUTICALS PLC
|
JAZZ |
1.36%
|
BIONTECH SE-ADR
|
BNTX |
1.16%
|
PTC THERAPEUTICS INC
|
PTCT |
1.04%
|
PRAXIS PRECISION MEDICINE
|
PRAX |
1.03%
|
VERACYTE INC
|
VCYT |
1.02%
|
IQVIA HOLDINGS INC
|
IQV |
1.01%
|
REVOLUTION MEDICINES INC
|
RVMD |
0.97%
|
STOKE THERAPEUTICS INC
|
STOK |
0.95%
|
KINIKSA PHARMACEUTICALS I
|
KNSA |
0.93%
|
INSMED INC
|
INSM |
0.92%
|
ROYALTY PHARMA PLC- CL A
|
RPRX |
0.92%
|
CRISPR THERAPEUTICS AG
|
CRSP |
0.91%
|
THERMO FISHER SCIENTIFIC
|
TMO |
0.9%
|
HINGE HEALTH INC-A
|
HNGE |
0.9%
|
SAMSUNG BIOLOGICS CO LTD
|
207940.KS |
0.87%
|
SARTORIUS AG-VORZUG
|
SRT3.DE |
0.84%
|
CADENCE DESIGN SYS INC
|
CDNS |
0.74%
|
ANAPTYSBIO INC
|
ANAB |
0.68%
|
AGILENT TECHNOLOGIES INC
|
A |
0.67%
|
ETON PHARMACEUTICALS INC
|
ETON |
0.67%
|
MODERNA INC
|
MRNA |
0.61%
|
BEAM THERAPEUTICS INC
|
BEAM |
0.6%
|
AXSOME THERAPEUTICS INC
|
AXSM |
0.55%
|
GENMAB A/S -SP ADR
|
GMAB |
0.54%
|
FIRST TRACKS BIOTHERAPEUT
|
TRAX |
0.51%
|
QIAGEN N.V.
|
QIA.DE |
0.5%
|
TG THERAPEUTICS INC
|
TGTX |
0.48%
|
ASTRAZENECA PLC
|
AZN.L |
0.47%
|
VERADERMICS INC
|
MANE |
0.45%
|
ROIVANT SCIENCES LTD
|
ROIV |
0.45%
|
GLAUKOS CORP
|
GKOS |
0.43%
|
MINERALYS THERAPEUTICS IN
|
MLYS |
0.39%
|
ARCUTIS BIOTHERAPEUTICS I
|
ARQT |
0.36%
|
CELCUITY INC
|
CELC |
0.36%
|
CORTEVA INC
|
CTVA |
0.36%
|
COGENT BIOSCIENCES INC
|
COGT |
0.35%
|
RHYTHM PHARMACEUTICALS IN
|
RYTM |
0.32%
|
BIO-RAD LABORATORIES-A
|
BIO |
0.29%
|
TARSUS PHARMACEUTICALS IN
|
TARS |
0.27%
|
BEONE MEDICINES LTD-ADR
|
ONC |
0.26%
|
NEUROGENE INC
|
NGNE |
0.17%
|
SAMSUNG EPISHOLDINGS CO L
|
0126Z0.KS |
0.14%
|
GENEDX HOLDINGS CORP
|
WGS |
0.14%
|
LIQUIDIA CORP
|
LQDA |
0.08%
|
ULTRAGENYX PHARMACEUTICAL
|
RARE |
0.07%
|
CASH
|
CASH |
0.06%
|
SAMSUNG BIO RTS
|
SAMSUNG.BIO.RTS |
0%
|
OMNIAB INC - 15.00 EARNOU
|
2200964 |
0%
|
OMNIAB INC - 12.5 EARNOUT
|
2200963 |
0%
|
Net Current Assets
|
Net.Current.Assets |
-0.05%
|
| Sector | Weight |
|---|---|
|
Health care
|
96.90% |
|
Financials
|
2.00% |
|
Information Technology
|
0.74% |
|
Materials
|
0.36% |
Franklin Genomic Advancements ETF (HELX) share price today is $41.665.
Yes, Indians can buy shares of Franklin Genomic Advancements ETF (HELX) on Vested. To buy HELX from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Franklin Genomic Advancements ETF (HELX) on Vested. You can start investing in Franklin Genomic Advancements ETF (HELX) with a minimum investment of $1.
The 52-week high price of Franklin Genomic Advancements ETF (HELX) is $45.58. The 52-week low price of Franklin Genomic Advancements ETF (HELX) is $31.24.
The stock symbol (or ticker) of Franklin Genomic Advancements ETF is HELX.
Yes, you can setup SIP in Franklin Genomic Advancements ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of HELX on the Vested app.
The expense ratio of Franklin Genomic Advancements ETF (HELX) is 0.5%.
Link copied